ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,892Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 1677

$751K Total Retail Price of All Prescriptions

Rank: 145 out of 1677

594 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 594 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 594 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,407 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 742 608 1 1
LISINOPRIL 596 455 2 3
AMLODIPINE BESYLATE 550 470 3 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 478 424 4 17
OMEPRAZOLE 471 371 5 6
FUROSEMIDE 451 368 6 8
METFORMIN HCL 428 310 7 7
POTASSIUM CHLORIDE 409 338 8 14
HYDROCHLOROTHIAZIDE 393 315 9 9
LEVOTHYROXINE SODIUM 381 346 10 5
METOPROLOL TARTRATE 363 301 11 12
SERTRALINE HCL 329 258 12 26
RANITIDINE HCL 307 245 13 18
WARFARIN SODIUM 288 209 14 24
METOPROLOL SUCCINATE 267 204 15 23
TRAMADOL HCL 232 197 16 16
HYDROCODONE-ACETAMINOPHEN 225 164 S3 17 4
LOSARTAN POTASSIUM 224 169 18 25
ATORVASTATIN CALCIUM 217 173 19 13
GLIPIZIDE ER 213 145 20 78
NEXIUM 194 149 21 19
MELOXICAM 193 171 22 27
AMITRIPTYLINE HCL 161 106 R 23 63
LOVASTATIN 158 141 24 35
ISOSORBIDE MONONITRATE ER 157 137 25 73
CLOPIDOGREL 151 122 26 32
GABAPENTIN 150 124 27 11
CARVEDILOL 148 116 28 20
TAMSULOSIN HCL 148 119 28 34
CLONIDINE HCL 140 115 30 36
CITALOPRAM HBR 128 71 31 22
GLIPIZIDE XL 122 122 32 123
TRAZODONE HCL 121 76 33 37
TRIAMTERENE-HCTZ 121 103 33 61
PRAVASTATIN SODIUM 120 113 35 10
AZITHROMYCIN 115 97 36 38
ZOLPIDEM TARTRATE 114 91 37 15
ALLOPURINOL 109 88 38 31
DILTIAZEM 24HR CD 104 60 39 156
FENTANYL 104 104 S2 39 103
PLAVIX 98 82 41 47
BISOPROLOL-HYDROCHLOROTHIAZIDE 96 74 42 107
DIOVAN HCT 95 86 43 66
ADVAIR DISKUS 95 89 43 54
ATENOLOL 91 61 45 21
VERAPAMIL ER 90 78 46 86
DONEPEZIL HCL 88 87 47 30
DIGOXIN 82 70 48 71
RISPERIDONE 82 58 48 60
CIPROFLOXACIN HCL 82 71 48 57
LANTUS 78 58 51 44
LOSARTAN-HYDROCHLOROTHIAZIDE 77 77 52 42
PAROXETINE HCL 76 41 53 67
NAMENDA 76 76 53 39
FAMOTIDINE 75 63 55 41
TRICOR 75 30 55 100
LIPITOR 75 62 55 101
DIOVAN 74 74 58 45
LEVOFLOXACIN 74 56 58 84
FLUTICASONE PROPIONATE 74 57 58 29
FINASTERIDE 73 69 61 130
VENLAFAXINE HCL ER 73 53 61 92
CYCLOBENZAPRINE HCL 68 49 R 63 52
PREDNISONE 67 43 64 40
AMOXICILLIN 66 57 65 94
GLIMEPIRIDE 65 49 66 33
GLYBURIDE-METFORMIN HCL 64 30 R 67 121
FLUOXETINE HCL 63 28 68 49
GLIPIZIDE 63 47 68 56
KLOR-CON M20 61 50 70 65
SPIRONOLACTONE 60 34 71 88
HYDRALAZINE HCL 60 59 71 69
PROAIR HFA 59 48 73 50
MECLIZINE HCL 58 58 74 110
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 49 74 85
POLYETHYLENE GLYCOL 3350 57 49 76 76
INSULIN SYRINGE 56 41 77 72
IBUPROFEN 55 34 78 83
ALENDRONATE SODIUM 54 54 79 43
METOCLOPRAMIDE HCL 53 50 80 124
PHENYTOIN SODIUM EXTENDED 53 17 80 112
HUMULIN 70-30 52 31 82 219
NOVOLIN R 51 34 83 133
SINGULAIR 50 41 84 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.